Close

Lilly To Provide Detailed Update Of Pipeline And R&D Strategy At Upcoming Investment Community Meeting

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Drug Formulation Market Growth Forecast 2025-2035

The Future of Medicine: A Comprehensive Insight into the...

Small Molecule API Market Growth Analysis and Future Trends

Small Molecule API Market Size, Share, and Growth Analysis The...

Regulatory Changes in Europe Impact APIs and Excipients

There have been big changes in the pharmaceutical industry...

Regenerative Medicine Makeover Via Artificial Intelligence

While the regenerative medicine spectrum continues its upward trend,...

Eli Lilly and Company announced it will host a meeting for the investment community, including institutional investors, sell-side analysts, ratings agency representatives, and financial and business media.

World pharma today/Industry reports/- The meeting will take place Tuesday, May 24, 2016, from 10:00 a.m. (EDT) until approximately 3:00 p.m., inNew York City.

The investment community meeting will focus on Lilly’s research and development opportunities in diabetes, immunology, oncology and pain. It follows a similar meeting in December 2015 to review the company’s broad Alzheimer’s disease pipeline. The presentations will include discussion of new indications and line extensions for a number of established products as well as late-stage and select earlier-stage new molecular entities. There will be Q&A opportunities throughout the meeting.

A live webcast of the Lilly investment community meeting, along with presentation slides, will be available through a link on the investor section of Lilly’s website at https://investor.lilly.com/events.cfm. An audio replay will also be available for approximately one month.

Because of limited space, advance registration is required. Media interested in attending in person should contactMolly McCully at (317) 478-5423. Investors interested in attending should contact Edward Villacorta at (317) 433-1805.

Latest stories

Related stories

Drug Formulation Market Growth Forecast 2025-2035

The Future of Medicine: A Comprehensive Insight into the...

Small Molecule API Market Growth Analysis and Future Trends

Small Molecule API Market Size, Share, and Growth Analysis The...

Regulatory Changes in Europe Impact APIs and Excipients

There have been big changes in the pharmaceutical industry...

Regenerative Medicine Makeover Via Artificial Intelligence

While the regenerative medicine spectrum continues its upward trend,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back